Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Early Treatment Enhances Surgery Benefit in Carotid Stenosis

By HospiMedica International staff writers
Posted on 26 Jun 2012
A new study shows that for patients with symptomatic carotid stenosis, endarterectomy has the greatest benefit among those treated within seven days of the most recent event.

Researchers at Innsbruck Medical University (Austria) performed a meta-analysis of three large randomized European trials that compared stenting versus endarterectomy surgery for symptomatic carotid stenosis. More...
The analysis included 2,839 patients (mean age 70; 72% male). Of these, 9% were treated within 7 days of their event, 16% were treated 8 to 14 days after their event, and 76% were treated beyond 14 days.

The results showed that the rate of any stroke or death within 30 days of the procedure was significantly higher for stenting (7.7%) than for surgery (3.8%), regardless of the time since the latest event. The difference declined for those treated 8 to 14 days after their event, and beyond 14 days. Further adjustment for age, sex, and type of qualifying event attenuated the risk ratios, but there was still a significantly higher rate associated with stenting among those treated within 7 days. Similar trends were seen for the composite of disabling stroke and death, although the individual risk ratios were not statistically significant. The study was presented at the annual meeting of the Society for Vascular Surgery (SVS), held during June 2012 in National Harbor (MD, USA).

“With those results, you should avoid applying carotid artery stenting to your symptomatic patients when they're treated early,” said lead author and study presenter Gustav Fraedrich, MD. “And they should be treated early.”

Endarterectomy is a surgical procedure to remove the atheromatous plaque material, or blockage, in the lining of an artery. The procedure is widely used on the carotid artery of the neck as a way to reduce the risk of stroke, particularly when the carotid artery is narrowed by more than 70%; however, a carotid endarterectomy may itself cause a stroke at the time of operation.

Related Links:

Innsbruck Medical University




Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Patient Monitoring System
AlarmSense
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.